Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs EFV✓SelectedUSD · EFVGSK vs EFV performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs EFV

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+41.1%
EFV return
+83.6%
Excess return
-42.4%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioEFVExcessAlpha
1D-0.1%-2.1%+2.0%+1.2%
7D-5.3%-7.2%+1.9%-0.8%
30D-3.7%-5.7%+2.0%-0.1%
3M-7.3%-8.0%+0.8%-2.3%
6M-4.2%-2.4%-1.9%-2.8%
YTD+0.9%+7.7%-6.8%-3.7%
1Y+7.3%+16.8%-9.5%-2.5%
3Y+52.7%+70.5%-17.7%+11.4%
All+41.1%+83.6%-42.4%-3.0%

Cumulative growth

Daily Returns

Daily percentage return beside EFV.

Daily Out/Under-Performance

Portfolio return minus EFV return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × EFV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded EFV wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling